Menu
HERO IMAGE Results

References

Not an actual patient.

 

1/2 - J.Fares. A prospective study of evaluation of the results achieved with the application of PERFECTHA® Subskin, a new gel of hyaluronic acid non animal origin for malar and mental enhancement.

3 - Park KY1, Kim HK, Kim BJ. Comparative study of hyaluronic acid fillers by in vitro and in vivo testing. J Eur Acad Dermatol Venereol. 2014 May;28(5):565-8.

    Cell toxicity was tested on fibroblast cell line. Cell viability was assessed neat and in 1/2 and 1/4 dilutions using 0.2g/ml HA filler.

4 - Koenig B., Analysis of IL-8 inducing potential from human effector cells. Evaluation of inflammatory potential of Perfectha product line by measurement of IL-8 release from adherent macrophages.

    Study Report, MMD, August 2020.

5 - Post Market Data from July 2012 to August 2020.

6 - Talarico S. et al. Evaluation of the safety and efficacy of a new filler with hyaluronic acid for the treatment of nasolabial folds and lip contour; Surg. Cosmet. Dermatol.2010;2(2):83-6.

7 - Park KY1, Kim HK, Kim BJ. Comparative study of hyaluronic acid fillers by in  vitro and in vivo testing. J Eur Acad Dermatol Venereol. 2014 May;28(5):565-8.

8 - Da Costa et al. Durability of Three Different Types of Hyaluronic Acid Fillers in Skin: Are There Differences Among Biphasic, Monophasic Monodensified, and Monophasic Polydensified Products?; Aesthet. Surg. J. 2016, 1-9.

9 -  Internal data - Evaluation and comparison study of the G’ rheological properties of PERFECTHA® with the main competitors HA-based dermal fillers. This study was conducted internally on a TA Instruments DHR-2 rheometer with a 25mm parallel-plate geometry.        Frequency sweep tests were performed on samples between 0.1 and 100 rad/s at a 1% strain in order to match the gels Newtonian Plateau and using plate-plate geometry.

10 - Internal Data: Material: Brookfield Texturometer CT3-4500 with a TA51 probe. Extrusion speed: 12mm/s over distance of 15mm.

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them.

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions. Perfectha is for intradermal and subcutaneous application and is implanted in the areas of the face and hands to fill skin depressions and also for the augmentation of tissue volume.

 

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type, there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules, etc.), pain (which may be temporary or persistent in nature), transient hematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Perfectha distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

 

For a full list of contraindications, warnings, and precautions for this product please visit here for a copy of the Product Instructions for Use.